Table 1.
Multiple Daily Insulin Injections | Insulin pumps Via Private Health Insurance | Insulin pumps Via Subsidised Pump Program | |
---|---|---|---|
n | 434 | 424 | 61 |
Age* (years) | 12.2 (4.0) | 12.5 (4.0) | 9.0 (4.9) |
Sex, n (%) | |||
Males | 234 (54) | 210 (49.5) | 36 (59) |
Females | 200 (46) | 214 (50.5) | 25 (41) |
Diabetes Duration* (years) | 3.2 (3.3) | 5.9 (3.8) | 2.4 (3.1) |
HbA1c* % | 8.4 (1.9) | 8.2 (1.5) | 8.1 (1.2) |
mmol/mol | 68 (20) | 66 (16) | 65 (13) |
SEIFA decile# n (%) | |||
1-3 | 103 (24) | 83 (20) | 23 (38) |
4-7 | 155 (35) | 158 (37) | 22 (36) |
8-10 | 159 (37) | 162 (38) | 16 (26) |
N/A | 17 (4) | 21 (5) | 0 |
Location n (%) | |||
City and major regional areas | 339 (78) | 301 (71) | 42 (69) |
Regional areas | 78 (18) | 102 (24) | 19 (31) |
N/A | 17 (4) | 21 (5) | 0 (0) |
Ethnicity** n (%) | |||
Oceanian (Australia, NZ) | 289 (66.6) | 231 (55) | 41 (67) |
Northwest European | 21 (4.8) | 33 (7.8) | 5 (8) |
Southern and Eastern European | 7 (1.6) | 10 (2.4) | 0 (0) |
North African and Middle Eastern | 6 (1.4) | 4 (0.9) | 4 (7) |
Sub Saharan African | 16 (3.7) | 13 (3.1) | 2 (3) |
South-East Asian | 8 (1.8) | 2 (0.5) | 0 (0) |
North-East Asian | 4 (0.9) | 3 (0.7) | 0 (0) |
Southern and Central Asian | 13 (3) | 11 (2.6) | 1 (2) |
People of Americas | 2 (0.5) | 2 (0.5) | 0 (0) |
Not available | 68 (15.7) | 115 (27.1) | 8 (13) |
CGM use n (%) | 386 (89) | 400 (94) | 55 (90) |
*Values in Mean (SD),#SEIFA: Socio-Economic Indexes for Areas (SEIFA) decile. A lower decile represents relatively greater disadvantage, while a higher decile indicates relative lack of disadvantage.
**Self-reported ethnicity is categorised according to the Australian Bureau of Statistics’ (ABS) Australian Standard Classification of Cultural and Ethnic Groups (ASCCEG), Second Edition, 2011.